Search Results - "Rubbert-Roth A"

Author Index.

Source: International Journal of Rheumatic Diseases. Jan2024 Supplement 1, Vol. 27, p435-448. 14p.

Author Index.

Source: International Journal of Rheumatic Diseases. Jun2024 Supplement 1, Vol. 27, p1-5. 5p.

Pausing drugs and spacing vaccines: an open question - Authors' reply.

Authors: Rubbert-Roth A Schmiedeberg K von Kempis J

Source: The Lancet. Rheumatology [Lancet Rheumatol] 2021 Oct; Vol. 3 (10), pp. e683-e684. Date of Electronic Publication: 2021 Sep 22.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2665-9913 (Electronic) Linking ISSN: 26659913 NLM ISO Abbreviation: Lancet Rheumatol Subsets: PubMed not MEDLINE

Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study.

Authors: Rubbert-Roth, Andrea Kato, Koji Haraoui, Boulos et al.

Source: Rheumatology & Therapy. Oct2024, Vol. 11 Issue 5, p1197-1215. 19p.

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study.

Authors: Baldi, Caterina Celletti, Eleonora Bugatti, Serena et al.

Source: Rheumatology & Therapy. Jun2026, Vol. 13 Issue 3, p767-784. 18p.

Golimumab for the Treatment of Rheumatoid Arthritis: A Narrative Review of Pivotal Randomized Trials and Real-World Studies.

Authors: Kiltz, Uta Chen, Yi-Ming Rubbert-Roth, Andrea et al.

Source: Rheumatology & Therapy. May2026, p1-32. 32p.

Author Index.

Source: International Journal of Rheumatic Diseases. 2023 Suppl, Vol. 26, p389-401. 13p.

Author Index.

Source: International Journal of Rheumatic Diseases. Apr2019 Supplement S3, Vol. 22, p227-237. 11p.

Author Index.

Source: International Journal of Rheumatic Diseases. Oct2020 Supplement S1, Vol. 23, p354-367. 14p.

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.

Authors: Rubbert-Roth, Andrea Kakehasi, Adriana M. Takeuchi, Tsutomu et al.

Source: Rheumatology & Therapy. Feb2024, Vol. 11 Issue 1, p97-112. 16p.

Transcriptomic Evaluation of Hollow Microneedles-Mediated Drug Delivery for Rheumatoid Arthritis Therapy.

Authors: Liu, Zhibo Li, Xiaotong Liu, Suhang et al.

Source: Biosensors (2079-6374); Dec2025, Vol. 15 Issue 12, p782, 32p

Utility of cranial and cervical vessel magnetic resonance imaging as a diagnostic aid in a patient with suspected giant cell arteritis.

Authors: Kresanov, P Nyman, M Parkkola, R et al.

Source: Scandinavian Journal of Rheumatology. Mar2026, Vol. 55 Issue 2, p151-153. 3p.

Real‐World Evidence of Upadacitinib Effectiveness in Moderate to Severe Atopic Dermatitis Patients in Saudi Arabia: A Retrospective Chart Review.

Authors: Saaty, Shawky E. L. Alshehri, Hamza Salim Alsharif, Osama et al.

Source: Dermatology Research & Practice. 7/15/2026, Vol. 2026, p1-14. 14p.

Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis of the Phase 2/3 SELECT-AXIS Studies.

Authors: Baraliakos, Xenofon Bessette, Louis de Vlam, Kurt et al.

Source: Rheumatology & Therapy. Jun2026, Vol. 13 Issue 3, p611-628. 18p.

Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort.

Authors: Parchão, António Monteiro, Carolina Araújo-Andrade, Leonardo et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3733. 13p.

A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation.

Authors: Heravi, Mansooreh Damough, Shadi Mafakher, Ladan et al.

Source: Applied Microbiology & Biotechnology; 10/9/2025, Vol. 109 Issue 1, p1-16, 16p

Clinical and Ultrasound Remission in Rheumatoid Arthritis Patients Treated with JAK Inhibitors: A Real-World Study.

Authors: Lasa-Teja, Carmen Fernández-Cabero, Juan José Sánchez-Bilbao, Lara et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p278. 12p.

A neuroimmune circuit mediates cancer cachexia-associated apathy.

Authors: Zhu, Xiaoyue Aelita Starosta, Sarah Ferrer, Miriam et al.

Source: Science. 4/11/2025, Vol. 388 Issue 6743, p1-19. 19p.

Multiple Sclerosis-Associated Uveitis: A Case Report of Refractory Bilateral Chronic Granulomatous Panuveitis Successfully Treated with Tocilizumab.

Authors: Gil, William Lagrib, Hassan Olagne, Louis et al.

Source: Ocular Immunology & Inflammation. Nov2024, Vol. 32 Issue 9, p2264-2267. 4p.

Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data.

Authors: Rehberg, Markus Giegerich, Clemens Praestgaard, Amy et al.

Source: Rheumatology & Therapy. Dec2021, Vol. 8 Issue 4, p1921-1922. 2p.